Please enter your login details

News & Events

New Medicine - Insulin degludec

(4th January 2013)

NICE guidance for a new medicine - Insulin degludec so what is it? 

Insulin degludec (Tresiba) is an ultra-long-acting insulin analogue in development for basal insulin replacement therapy in adults (18 years or over) with type 1 or type 2 diabetes.

Link to the National Institute of Clinical Excellence (NICE) to read the full review.